Prospective Randomized Evaluation of a new Formulation: Efficacy of Rotigotine
Phase of Trial: Phase III
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms PREFER
- 12 Feb 2016 Results of pooled post-hoc analysis of this and two other trials (see profile 26754 and 10814) published in the Clinical Neuropharmacology
- 20 Apr 2015 Post-hoc analysis on pooled data presented at the 67th Annual Meeting of the American Academy of Neurology (AAN), according to a UCB media release.
- 26 Apr 2012 Results presented at the 64th Annual Meeting of the American Academy of Neurology, according to a UCB media release.